Paul McBarron
2021
In 2021, Paul McBarron earned a total compensation of $707.9K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary at Cyclacel Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Bonus | $140,145 |
|---|---|
| Option Awards | $263,000 |
| Salary | $282,177 |
| Other | $22,538 |
| Total | $707,860 |
McBarron received $282.2K in salary, accounting for 40% of the total pay in 2021.
McBarron also received $140.1K in bonus, $263K in option awards and $22.5K in other compensation.
Rankings
In 2021, Paul McBarron's compensation ranked 9,855th out of 12,415 executives tracked by ExecPay. In other words, McBarron earned more than 20.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,855 out of 12,415 | 21st |
Division Manufacturing | 4,359 out of 5,508 | 21st |
Major group Chemicals And Allied Products | 1,941 out of 2,378 | 18th |
Industry group Drugs | 1,724 out of 2,099 | 18th |
Industry Pharmaceutical Preparations | 1,284 out of 1,549 | 17th |
Source: SEC filing on April 26, 2022.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2021.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020